Unstable or High Risk Plaque: How Do We Approach It?
作者信息
Mehta A B, Shah Sameer
机构信息
Director of Cardiology, Jaslok Hospital and Research Centre, Mumbai.
Registrar, Jaslok Hospital and Research Centre, Mumbai.
出版信息
Med J Armed Forces India. 2006 Jan;62(1):2-7. doi: 10.1016/S0377-1237(06)80141-3. Epub 2011 Jul 21.
Abstract
摘要
相似文献
1
Unstable or High Risk Plaque: How Do We Approach It?
Med J Armed Forces India. 2006 Jan;62(1):2-7. doi: 10.1016/S0377-1237(06)80141-3. Epub 2011 Jul 21.
2
Pathology of unstable plaque: correlation with the clinical severity of acute coronary syndromes.
J Am Coll Cardiol. 1997 Sep;30(3):694-702. doi: 10.1016/s0735-1097(97)00213-1.
3
Feasibility of diagnosing unstable plaque in patients with acute coronary syndrome using iMap-IVUS.
J Zhejiang Univ Sci B. 2015 Nov;16(11):924-30. doi: 10.1631/jzus.B1500206.
4
[Pathophysiological bases of unstable coronary syndrome].
Herz. 2001 Apr;26 Suppl 1:2-8. doi: 10.1007/pl00014027.
5
Unstable coronary plaque and its relation to coronary calcium.
Circulation. 2001 Oct 2;104(14):1682-7. doi: 10.1161/hc3901.093339.
6
Lipoprotein(a) and inflammation in human coronary atheroma: association with the severity of clinical presentation.
J Am Coll Cardiol. 1998 Dec;32(7):2035-42. doi: 10.1016/s0735-1097(98)00469-0.
7
Targeting the unstable plaque in acute coronary syndromes.
Clin Ther. 2013 Aug;35(8):1099-107. doi: 10.1016/j.clinthera.2013.07.332.
8
Comparision of high sensitivity C-reactive protein and matrix metalloproteinase 9 in patients with unstable angina between with and without significant coronary artery plaques.
Chin Med J (Engl). 2011 Jun;124(11):1657-61.
9
Coronary plaque rupture with subsequent thrombosis typifies the culprit lesion of non-ST-segment-elevation myocardial infarction, not unstable angina: non-ST-segment-elevation acute coronary syndrome study.
Heart Vessels. 2017 Mar;32(3):241-251. doi: 10.1007/s00380-016-0862-6. Epub 2016 Jun 21.
10
Inflammation as a possible link between coronary and carotid plaque instability.
Circulation. 2004 Jun 29;109(25):3158-63. doi: 10.1161/01.CIR.0000130786.28008.56. Epub 2004 Jun 7.
引用本文的文献
1
Emerging Nuclear Medicine Imaging of Atherosclerotic Plaque Formation.
J Imaging. 2022 Sep 27;8(10):261. doi: 10.3390/jimaging8100261.
2
Clinical Molecular Imaging for Atherosclerotic Plaque.
J Imaging. 2021 Oct 13;7(10):211. doi: 10.3390/jimaging7100211.
3
A Nano-Emulsion Platform Functionalized with a Fully Human scFv-Fc Antibody for Atheroma Targeting: Towards a Theranostic Approach to Atherosclerosis.
Int J Mol Sci. 2021 May 14;22(10):5188. doi: 10.3390/ijms22105188.
4
Prospective Medical Studies in the Armed Forces.
Med J Armed Forces India. 2007 Apr;63(2):206. doi: 10.1016/S0377-1237(07)80088-8. Epub 2011 Jul 21.
5
Atheromas feel the pressure: biomechanical stress and atherosclerosis.
Am J Pathol. 2010 Jul;177(1):4-9. doi: 10.2353/ajpath.2010.090615. Epub 2010 Jun 17.
6
Matrix vesicles in the fibrous cap of atherosclerotic plaque: possible contribution to plaque rupture.
J Cell Mol Med. 2008 Oct;12(5B):2073-82. doi: 10.1111/j.1582-4934.2008.00230.x. Epub 2008 Jan 11.
本文引用的文献
1
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery.
N Engl J Med. 2003 Oct 2;349(14):1315-23. doi: 10.1056/NEJMoa035071.
2
Study of antirestenosis with the BiodivYsio dexamethasone-eluting stent (STRIDE): a first-in-human multicenter pilot trial.
Catheter Cardiovasc Interv. 2003 Oct;60(2):172-8; discussion 179. doi: 10.1002/ccd.10636.
3
Pilot trial of oral rapamycin for recalcitrant restenosis.
Circulation. 2003 Apr 8;107(13):1722-4. doi: 10.1161/01.CIR.0000066282.05411.17. Epub 2003 Mar 24.
4
Clinical and angiographic outcome of patients with mild coronary lesions treated with balloon angioplasty or coronary stenting. Implications for mechanical plaque sealing.
Eur Heart J. 2003 Mar;24(6):541-51. doi: 10.1016/s0195-668x(02)00422-0.
5
Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study).
J Am Coll Cardiol. 2002 Dec 4;40(11):1935-42. doi: 10.1016/s0735-1097(02)02562-7.
6
Relationship between coronary artery remodeling and plaque vulnerability.
Circulation. 2002 Feb 26;105(8):939-43. doi: 10.1161/hc0802.104327.
7
Detection of lipid pool, thin fibrous cap, and inflammatory cells in human aortic atherosclerotic plaques by near-infrared spectroscopy.
Circulation. 2002 Feb 26;105(8):923-7. doi: 10.1161/hc0802.104291.
8
The thin-cap fibroatheroma: a type of vulnerable plaque: the major precursor lesion to acute coronary syndromes.
Curr Opin Cardiol. 2001 Sep;16(5):285-92. doi: 10.1097/00001573-200109000-00006.
9
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.
N Engl J Med. 2001 Aug 16;345(7):494-502. doi: 10.1056/NEJMoa010746.
10
Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease.
Circulation. 2001 Jul 24;104(4):387-92. doi: 10.1161/hc2901.093188.
Zotero 插件